Stem cells might provide unlimited supply of transplantable cells for β-cell replacement therapy in diabetes. The human limbus is a highly specialized region hosting a well-recognized population of epithelial stem cells, which sustain the continuous renewal of the cornea, and the recently identified stromal fibroblast-like stem cells (f-LSCs), with apparent broader plasticity. However, the lack of specific molecular markers for the identification of the multipotent limbal subpopulation has so far limited the investigation of their differentiation potential. In this study we show that the human limbus contains uncommitted cells that could be potentially harnessed for the treatment of diabetes. Fourteen limbal biopsies were obtained from patients undergoing surgery for ocular diseases not involving the conjunctiva or corneal surface. We identified a subpopulation of f-LSCs characterized by robust proliferative capacity, expressing several pluripotent stem cell markers and exhibiting self-renewal ability. We then demonstrated the potential of f-LSCs to differentiate in vitro into functional insulin-secreting cells by developing a four-step differentiation protocol that efficiently directed f-LSCs towards the pancreatic endocrine cell fate. The expression of specific endodermal, pancreatic, islet, and β-cell markers, as well as functional properties of f-LSC-derived insulin-producing cells, were evaluated during differentiation. With our stage-specific approach, up to 77% of f-LSCs eventually differentiated into cells expressing insulin (also assessed as C-peptide) and exhibited phenotypic features of mature β-cells, such as expression of critical transcription factors and presence of secretory granules. Although insulin content was about 160-fold lower than what observed in adult islets, differentiated cells processed ϳ98% of their proinsulin content, similar to mature β-cells. Moreover, they responded in vitro in a regulated manner to multiple secretory stimuli, including glucose. In conclusion, f-LSCs represent a possible relevant source of autologous, transplantable, insulin-producing cells that could be tested for the reversal of diabetes. 73 74 CRISCIMANNA ET AL.
INTRODUCTION
virtually differentiate into any phenotype, might provide an unlimited supply of surrogate β-cells. However, their clinical application is affected by ethical and technical Type 1 diabetes is caused by the autoimmune destruction of pancreatic β-cells, which leads to their virtually challenges. Hence, adult multipotent stem cells are now being widely evaluated. Nevertheless, the scarcity of the complete eradication (2). Currently available options for β-cell replacement therapy (i.e., whole pancreas or iso-source, the invasive procedures often required to isolate these cells, and their restricted differentiation potential lated islet transplantation) are limited by the shortage of organ donors and the need for life-long immunosuppres-have limited their use in translational medicine (1). The purpose of our study was to identify a novel pop-sion (33). A variety of stem cells may be potentially harnessed for the treatment of type 1 diabetes. Embry-ulation of uncommitted cells that could offer advantages over the countless stem cell sources proposed so far for onic stem cells (ESCs), which are able to self-renew and β-cell replacement therapy. The limbus is a highly were plated in cell culture-treated flasks following fine dissection with a sterile blade. After 24-48 h, adherent specialized region of the eye hosting a well-recognized population of epithelial stem cells (LESCs), which con-colonies of f-LSCs and small cuboidal cells (epithelial) were obtained. At the same time, floating spherical cell tinuously renew the corneal surface (8) . The limbal niche is characterized by stromal invaginations that pro-clusters or "limbospheres" started forming. Limbospheres progressively increased in number and size and attached vide anatomical and functional dimensions to maintain "stemness," protect stem cells from traumatic and envi-to the plastic surface, eventually generating highly proliferating fibroblast-like outgrowths (see Fig. S1A , avail-ronmental insults, allow epithelial-mesenchymal interactions, and supply access to chemical signals that able at: https://sites.google.com/site/endocrinologycgior dano/cell-transplantation-journal_supplemental-material). diffuse from the rich underlying vascular network (14) . A critical advantage of limbal cells is that they are easily
To better select f-LSCs from epithelial cells, forming limbospheres were transferred into new flasks. Limbal accessible with a well-established and minimally invasive procedure (13, 22, 35) . LESCs have been widely cells were cultured in F12/DMEM medium supplemented with 10% embryonic stem cell-tested fetal characterized (4, [8] [9] [10] 12, 14) and investigated for their differentiation potential, which seems to be restricted, bovine serum (FBS; PAA), 1× insulin-transferrin-selenium (ITS; PAA), and 4 ng/ml basic fibroblast growth the corneal fate. However, human ocular stem cell research has been mainly focused on the tissue-specific factor (bFGF; Sigma-Aldrich) (expansion medium). Cultures were maintained in 5% CO 2 in a humidified incu-differentiation that may be of clinical significance in the context of eye diseases, as demonstrated by their clinical bator at 37°C. Population doublings were calculated as [log 10 (final cell number/starting cell number)/log 10 2]. use in ocular surface reconstruction (13, 22, 35) . There is recent evidence that the limbal niche also hosts stromal Karyotype analysis was performed by cytogenetic standard protocol on all primary cell cultures. fibroblast-like stem cells (f-LSCs), with apparent multilineage transdifferentiation potential (11, 12, 28) . Pheno-Flow Cytometry type of f-LSCs is reportedly characterized by variable expression of several stem cells markers, which are dis-Cells were treated with FcR blocking reagent (Miltenyi Biotec) and incubated with primary antibody tinct from those described for LESCs (4, 9, 10) . However, the lack of agreement on specific molecular hallmarks at 4°C for 20 min. Cells were washed twice with PBS and incubated with secondary antibodies at 4°C for 20 for the identification of the pluripotent subpopulation among the limbal stromal cells has so far limited the min in the dark. Intracellular staining was performed using Cytofix/Cytoperm and Perm/Wash buffer (BD investigation of their differentiation potential to a few studies (11, 28) .
Pharmingen), according to the manufacturer's instructions. The sources of antibodies and dilutions used are summa-Here we describe a subpopulation of f-LSCs characterized by robust proliferative capacity, stable expression rized in Table S1A (see supplementary material at: https://sites.google.com/site/endocrinologycgiordano/cell-of several pluripotent stem cell markers, and self-renewal ability. We then demonstrate that f-LSCs are able to transplantation-journal_supplemental-material). Freshly isolated peripheral blood mononuclear cells (PBMCs) generate pancreatic endocrine cells. To this end, we have developed a four-step differentiation protocol aimed at and HeLa cells were used as positive controls for hematopoietic markers and p63(∆N), respectively. Data were directing f-LSCs through a series of intermediates similar to those occurring during pancreatic organogenesis, acquired on a FACSCalibur and analyzed using CELL Quest Pro software (Becton Dickinson) and are repre-efficiently leading to production of functional hormoneexpressing cells. With our stage-specific approach we sentative of at least five independent experiments. obtained up to 77% of insulin-producing cells. More Assessment of Self-Renewal Ability importantly, differentiated f-LSCs possessed the ability to secrete C-peptide in response to glucose and other Prior to assay, cells were sorted for stage specific embryonic antigen 4 (SSEA4) to ensure a purified stimuli, similar to mature β-cells. Cells were differentiated in culture slides (BD Biosci-Invitrogen), according to the manufacturer's instrucences) and stained at different time points in order to tions. Cells were then cultured either in expansion preserve the morphology of islet-like clusters. Cells medium or in RPMI-1640 supplemented with 10% FBS were fixed for 15 min at room temperature (RT) in 2% (basal medium), fixed with 2% paraformaldehyde at 24, (w/v) paraformaldehyde, permeabilized with 0.1% PBS/ 48, and 72 h, and stained for SSEA4. Images were Triton X-100 (Sigma-Aldrich), washed in PBS, and acquired with DM IRB inverted microscope equipped blocked for 30 min in 3% PBS/BSA (bovine serum with DC300F digital camera system. Alternatively, selfalbumin). Primary antibodies were incubated for 24 h at renewal assay was performed over a 15-day period as 4°C, while secondary antibodies were incubated for 1 h previously described (45) . Briefly, sorted SSEA4 + cells at RT. The sources of antibodies and dilutions used are were cultured as described above and SSEA4 expression summarized in Table S1C (supple-Activin A (Peprotech); in stage 2, cells were treated for 3-4 days with RPMI-1640 supplemented with 2% mental material). Horseradish peroxidase-conjugated secondary antibodies (Santa Cruz Biotechnology) and embryonic stem cell-tested FBS and 50 ng/ml bFGF; in stage 3, cells were cultured for 3-4 days with advanced chemiluminescent substrate (SuperSignal West Pico, Pierce) were used for detection with a Bio-Rad Chemi-DMEM supplemented with 10% embryonic stem celltested FBS, 1% B27 (PAA), 2% N2 (PAA), and 1 mM doc XRS Imager. Data are representative of at least five independent experiments. nicotinamide (Sigma-Aldrich); in stage 4, cells were cultured for 3-4 days in advanced DMEM supplemented with 10% embryonic stem cell-tested FBS, 1% B27, Real-Time Quantitative PCR (qRT-PCR) 2% N2, 1 mM nicotinamide, and 50 ng/ml exendin-4 mRNA isolation and subsequent cDNA synthesis (Sigma-Aldrich).
were performed using µMACS One-step cDNA Kit (Miltenyi Biotec) according to the manufacturer's Protocol B. In stage 1 cells were cultured as described in protocol A; in stage 2 cells were treated instructions. PCR primers were purchased from Qiagen (QuantiTect Primer Assays, Qiagen) and are listed in for 3-4 days with RPMI-1640 supplemented with 2% embryonic stem cell-tested FBS (PAA) and with 50 ng/ Table S1D (supplemental material). All reactions were performed with Quantitect Sybr Green PCR Kit (Qiagen) ml FGF10 (Sigma-Aldrich); stage 3 was carried out in advanced DMEM supplemented with 1% B27, 50 ng/ml using a LightCycler 1.5 Instrument (Roche). Reactions were performed at least in triplicate. Specificity of the FGF10, and 2 µM retinoic acid (RA; Sigma-Aldrich); in stage 4 cells were cultured in advanced DMEM supple-amplified products was determined by melting peak analysis. Quantification for each gene of interest was mented with 1% B27 and 50 ng/ml exendin-4. All of the data represented were generated with protocol A using performed in relation to a standard curve represented by the appropriate cDNA plasmid. Quantified values were the same primary cell culture, except where differently indicated.
normalized against the housekeeping gene β-actin.
cDNA of human islets was obtained from adult cadav-micrograms of total proteins. We used 500,000 differentiated f-LSCs and an equal mass of islet equivalents eric donors as previously described (31) .
(IEQ) (ϳ250 islets with an estimate of 2,000 cells per Transmission Electron Microscopy IEQ) (31) . Data are representative of five independent experiments. Pellets were fixed for 20 min in 2% paraformaldehyde; postfixed for 15 min with 1% osmium tetroxide,
RESULTS
dehydrated through graded ethanol concentrations, and embedded in epoxy resin (Durcupan ACM). Sections (80 nm thick) were cut with an Ultracut-Reichert Microf-LSCs Express Pluripotent Markers and Exhibit tome, mounted on nickel grids, and stained with 1% ura-Self-Renewal Ability nyl acetate and lead citrate. Analysis was performed on a Zeiss EM 109 electron microscope.
Limbal explants were finely dissected with a sterile blade and cells were plated in cell culture-treated flasks.
Insulin Content and C-Peptide Release Assays
After 24-48 h, a few colonies of small cuboidal (epithe-(Static Incubation) lial) cells and several colonies of f-LSCs were observed. At the same time, the single cell suspension gave rise to After discarding differentiation media, cells (both monolayer and islet-like clusters) were washed several floating spherical cell clusters, which we termed "limbospheres." Limbospheres progressively increased in num-times and then incubated for 1 h in Krebs-Ringer solution with bicarbonate and HEPES [KRBH; 129 mM ber and size and after a few days attached to the plastic surface, eventually giving rise to highly proliferating NaCl, 4.8 mM KCl, 2.5 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 5 mM NaHCO 3 , 10 mM HEPES, 0.1% fibroblast-like outgrowths. f-LSCs soon prevailed after 1 week of culture; however, to better select f-LSCs from (w/v) BSA], followed by 1-h incubation in KRBH containing 2 mM D-glucose (basal condition). Cells were epithelial cells, forming limbospheres were transferred in new flasks. Upon replating, limbospheres exclu-then incubated for another 1 h in stimulating conditions with 20 mM D-glucose, 100 µM tolbutamide or 30 mM sively generated f-LSCs. Cell morphology and growth rate of f-LSCs are shown in Figure 1A and B; a sketch KCl, respectively (all from Sigma-Aldrich). Plates were incubated at 37°C on a rotating shaker and the superna-illustrating isolation of f-LSCs from limbal explants is shown in Figure S1A (supplemental material). Primary tant was sampled at basal conditions and at the time points 1, 2, 3, 5, 7, 10, 15, 30, and 60 min. C-peptide f-LSC cultures were obtained from all 14 limbal biopsies and maintained normal karyotype (46XX or 46XY) content and release were assessed with C-peptide ELISA Kit (Mercodia) on cell lysates or supernatants, respec-during long-term culture. Figure 1C shows a representative karyotype at P30, corresponding to ϳ60 popula-tively. Proinsulin content was measured on cell lysates with Proinsulin Elisa Kit (Mercodia). The fold increase tion doublings. Immunophenotype of f-LSCs was assessed by flow was calculated for each culture condition by dividing the C-peptide concentration in the stimulation superna-cytometry ( Fig. 1D ). Freshly digested limbal specimens (which included also epithelial cells) showed significant tant at 60 min by the C-peptide concentration in the basal supernatant. Total insulin content was calculated expression of the pluripotent stem cell marker SSEA4 (mean ± SD: 65.2 ± 7.6%; data not shown), which had as the sum of C-peptide (pM) and proinsulin (pM) per been previously proposed as a reliable marker for f-steady state up to the last day of the assay. Instead, cell proliferation (detected by BrdU) was observed during LSCs (11) . After 10-12 population doublings in stem cell expansion medium, or at earlier passages in primary the entire culture period. Assessment of apoptosis by Annexin V-FITC at the same time points demonstrated cultures obtained by subculturing limbospheres, the highly proliferating f-LSCs showed increased positivity that the decrease in SSEA4 expression overtime was not caused by cell death (<2.7%, data not shown). for SSEA4 (90.8 ± 7.6%). SSEA4 + f-LSCs coexpressed the stem cell markers octamer binding transcription fac-
Directed Differentiation of f-LSCs Cells Towards tor [OCT4; double positive (DP): 92.7 ± 4.3%], sex the Pancreatic Endocrine Phenotype determining region Y box 2 (SOX2; DP: 91.9 ± 5.6%), NANOG (DP: 98.6 ± 1.3%), c-KIT (DP: 93.6 ± 3.3%),
We developed a four-step protocol for differentiation of f-LSCs into pancreatic endocrine cells through a TRA 1-60 (DP: 95.3 ± 4.1%), TRA 1-81 (DP: 95.0 ± 3.1%), THY-1 (DP: 94.5 ± 3.6%), CD105 (DP: 88.3 ± series of intermediates mimicking in vivo pancreatic organogenesis. Stepwise, we added factors and supple-2.3%), and the limbal marker ATP-binding cassette subfamily G member 2 (ABCG2; DP: 94.9 ± 4.8%) (4, 9) .
ments known to direct/support pancreatic differentiation of embryonic stem cells, such as activin A, bFGF, B27, CD133 was weakly expressed or absent (DP: 5.2 ± 2.9% only in 4 out of 14 primary cultures; data not shown). f-N2, nicotinamide, and exendin-4 (protocol A, Fig. 3A ) (6,20,24,34). The substitution or addition of other mole-LSCS were also negative for CD34, CD45, human lymphocyte antigen (HLA)-DR, and the LESC marker cules, such as FGF10 and retinoic acid (RA), was also investigated based on previous evidence reporting ∆Np63 ( Fig. 1D) (10) . To exclude that the absence of these markers in f-LSCs was due to experimental arti-improvement in endoderm formation and increase in insulin content of ESC-derived surrogate β-cells (proto-facts, freshly isolated PBMCs and HeLa cells were used as positive controls (data not shown). The expression of col B, Fig. 3B ) (7,21). At stage 1 and 2 (days 1-7), we focused on generat-all stem cell markers was unaffected by long-term culture and was assessed up to 92 population doublings ing definitive endoderm (DE) and posterior foregut (PF).
During stage 1 we used high concentrations of activin (data not shown). The "stem-like" profile of f-LSCs was confirmed by qRT-PCR ( Fig. 1E ), which also showed A in serum-free media, while in stage 2 activin A was removed, and either bFGF (protocol A) or FGF10 (pro-expression of Kruppel-like factor 4 (KLF-4), c-MYC, and CD73. Table S2 (supplemental material) summa-tocol B) was added in the context of low FBS supplementation. Soon upon activin A removal, a consistent rizes the markers that identify f-LSCs.
f-LSCs were also evaluated for the ability to divide percentage of f-LSCs transitioned to DE as indicated by the remarkable upregulation of SOX17 and Forkhead asymmetrically, a key stem cell feature (Fig. 2 ). Prior to assay, cells were sorted for SSEA4 to ensure a purified Box-A2 (FOXA2) mRNAs ( Fig. 3C ) and the subsequent protein detection by immunofluorescence ( Fig. 4A, B ). SSEA4 + f-LSC population ( Fig. 2A ). Cells were then labeled with fluorescent dye CFSE in order to track cell Of note, differentiating cells progressively aggregated into spherical cell clusters resembling human islets. At division ( Fig. 2B ). Cells were either cultured in expansion medium (supporting maintenance of the pluripotent the beginning of stage 2 we also observed significant upregulation of pancreatic and duodenal homeobox 1 phenotype) or in a basal medium (and thus allowing asymmetric division). Immunofluorescence analysis per-(PDX1), which is indicative of PF formation (Fig. 3C ) (26) . PDX1 + cells could be detected in both the forming formed at 24, 48, and 72 h in basal medium showed increasing number of CFSE + /SSEA4 − cells, while sev-islet-like clusters and in the surrounding monolayer (89.3 ± 4.1% at the end of stage 2). PDX1 + cells coex-eral mitotic cells showed polarized SSEA4 distribution ( Fig. 2C and D, arrows) . In addition, flow cytometry pressed NK6 homeobox 1 (NKX6.1), which is characteristic of pancreatic epithelium (Fig. 4C ) (26) . Neurogenin analysis after 72 h showed that the number of SSEA4 + cells remained unchanged while the total cell population 3 (NGN3) expression, as expected, was transient and peaked at the end of stage 2, along with the increase of increased, thus suggesting asymmetric division. By contrast, at 72 h cells cultured in expansion medium main-ISL LIM homeobox 1 (ISL1), paired box gene 4 (PAX4), NKX6.1, and neurogenic differentiation 1 (NEUROD1), tained SSEA4 expression as their number progressively increased, indicating cells divided symmetrically during all transcription factors controlling endocrine cell differentiation ( Fig. 3C) (15, 16) . Indeed, low levels of these proliferation (data not shown). Asymmetrical division of SSEA4 + cells was further evaluated indirectly over a 15-pancreatic genes were already detected at the end of stage 1, thus suggesting that a high dose of activin A day period by culturing f-LSCs in the same conditions described above ( Fig. 2E ). SSEA4 expression detected alone was able to initiate transcription of DE and PF markers. Nevertheless, if activin A was not removed by flow cytometry gradually decreased from 98% on day 0 (after sorting) to 58% on day 8, and maintained a and either bFGF or FGF10 was added, generation of hormone-producing cells in the subsequent stages did ghrelin (GHRL) transcripts (Fig. 3C ). However, no hormone-producing cells were found by immunofluores-not take place or was significantly reduced (data not shown). By the end of stage 2, NGN3 showed a nuclear cence at this stage (Fig. 4E ). In addition, by day 8 the expression of stem cell markers was already negligible localization in a substantial number of PDX1 + cells, consistent with endocrine determination (Fig. 4D) . At the (supplemental information in Fig. 1) . At stage 3 (days 8-12), bFGF was removed and B27, end of stage 2, we also noted upregulation of glucose transporter 2 (GLUT2) and glucokinase (GCK), along N2, and nicotinamide were added to further improve the yield and maturation of pancreatic endocrine precursors with the appearance of insulin (INS), glucagon (GCG), somatostatin (SST), pancreatic polypeptide (PPY), and (protocol A). Alternatively, FGF10 was maintained for 3-4 more days, in the presence of B27 and RA (protocol 3C). Differentiating cells showed a perinuclear or polarized localization of proinsulin (C-PEP/PROINS), consis-B). At the end of this stage, by about 12 days of differentiation, we observed consistent upregulation of INS tent with immature phenotype (Fig. 4F ). By contrast, in later-stage cells the hormone filled and delineated the and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) (MAFA) mRNAs. Transcripts for cytoplasm (Fig. 4G ). The absence of NGN3 staining at this stage (data not shown), along with the very low levels GCG, SST, GHRL, and PPY were also detectable ( Fig. of NGN3 mRNA, indicated that the majority of cells halo surrounding a less dense core, a morphology that is characteristic of insulin-containing vesicles (Fig. 7C ). already underwent endocrine determination.
At stage 4 (days 13-15), the islet-like clusters Insulin Content and Insulin Release increased in number and size (Fig. 5A ). In addition, cells From Differentiated f-LSCs double stained for C-PEP/PROINS and INS, suggesting further maturation. Interestingly, in bigger islet-like
To confirm de novo synthesis and release of insulin, we investigated the ability to secrete C-peptide in clusters staining for proinsulin was more marked in the cells of the inner core, while outer cells stained strongly response to secretory stimuli ( Fig. 7D) (29) . Stimulation with 20 mM glucose, 100 µM of the secretagogue tolbu-for mature insulin (Fig. 5B ; video S1 in supplemental material). GLUT2, which is part of the "glucose sensor" tamide, or direct depolarization with 30 mM potassium chloride (KCl) resulted in a robust C-peptide secretion along with GCK, showed a similar localization (Fig.  5C ). By contrast, smaller islet-like cluster had a more in the culture medium during 2-h static incubation. All three stimuli showed rapid kinetics with a peak of secre-homogeneous C-PEP/PROINS and INS distribution ( Fig. 5D , E; video S2 in supplemental material). In some tion within 5 min. A biphasic profile was observed after glucose stimulation with a second phase of secretion islet-like clusters a few cells of the inner core also expressed GCG (Fig. 5E ). Rare single SST + and GCG + around 10 min from the beginning of incubation. Fold stimulation of C-peptide release over the respective cells were randomly found in the monolayer (Fig. 5F,  G) . A confocal image of an islet-like cluster is shown in basal condition during 1-h static incubation resulted in 4-to 6-fold increase after glucose stimulation, 5-to 11- Figure 6A . At this stage, almost all C-PEP/PROINS + cells also expressed MAFA and PDX1 (Fig. 6B ). West-fold increase after tolbutamide, and 8-to 12-fold after KCl (Fig. 7E ). C-peptide secretion after 1-h static incu-ern blot analysis expression confirmed protein expression of GLUT2, PDX1, and GCK (Fig. 6C) .
bation was 15-to 28-fold less than that observed for adult human islets incubated in the same conditions (Fig. No substantial differences were observed between protocol A and protocol B in inducing the expression 7F). To accurately evaluate the ability to process insulin, we measured both C-peptide and proinsulin by ELISA of the majority of islet and β-cell-specific transcription factors. However, concerning hormone production, pro-on cell lysates. Total insulin content in differentiated f-LSCs was about 160-fold lower than in adult human tocol A was more efficient in inducing formation of islet-like clusters. Minor differences were observed in islets. However, the average proportion of total insulin content attributable to C-peptide in differentiated f-LSCs the differentiation outcome among the primary cell cultures used.
was comparable to that of human islets (ϳ98%; range 97-99.5%) (Fig. 7G ). Morphology of an islet-like cluster after 1-h static incubation with 20 mM glucose is Quantification of Differentiated f-LSCs shown in Figure 7H . To quantify hormone-expressing cells, we performed flow cytometry after completing differentiation at stage DISCUSSION 4 ( Fig. 7A ). Analysis showed an average of 72.1 ± 5.3% Cultured human limbal epithelial stem cells have positive cells for C-PEP/PROINS, with higher rates been successfully used for corneal reconstruction. Howobtained with protocol A. GCG + and SST + cells were ever, human ocular stem cell research has been mainly 10.6 ± 2.4% and 8.2 ± 2.6%, respectively. qRT-PCR analfocused on the tissue-specific differentiation that may be ysis showed higher INS expression in the islet-like clusof clinical significance in the context of eye diseases. ters in comparison to monolayer cells (data not shown).
Here we show how the limbus hosts a fibroblast-like stem cell population that could be harvested for clinical Differentiated f-LSCs Possess Secretory Granules use in type 1 diabetes. The phenotypic characterization of f-LSCs has been variably described (11, 12, 28) . We To confirm the degree of maturation of hormoneexpressing cells, we investigated whether they formed have identified a core set of attributes that uniquely characterizes f-LSCs, such as the expression of the well-secretory granules. Confocal microscopy of C-PEP-and INS-stained cells showed a granulated pattern of the established stem cell surface antigens SSEA4, TRA 1-60, TRA 1-81, THY1, c-KIT, CD105, CD73, and the cytoplasm, consistent with the existence of secretory granules (Fig. 6B) (6) . Several INS + cells coexpressed limbal stem cell marker ABCG2. f-LSCs also expressed several nuclear transcription factors, such as OCT4, the vesicle protein synaptophysin (SYP), and flow cytometry analysis indicated an average percentage of coex-NANOG, SOX2, KLF-4, and c-MYC, which are involved in self-renewal and maintenance of pluripo-pression of 69.0 ± 3.9% (Fig. 7B ). Electron microscopy also revealed secretory granules in the cytoplasm and tency of both embryonic and adult stem cells (40, 44) . The LESC marker ∆Np63 was negative, confirming the next to the cell membrane. Some of them showed a clear nonepithelial nature of f-LSCs, while the absence of differentiation. At stage 1, transition to DE was demonstrated by the appearance of SOX17 (32,36) and FOXA2 CD34 and CD45 argues against a hematopoietic origin. f-LSCs did not express HLA-DR histocompatibility (23) . Of note, both transcription factors were persistently expressed up to stage 4, albeit at lower levels. This find-molecules on their surface. This feature could be advantageous in the transplantation setting as it might confer ing is obvious for FOXA2, being also a well-recognized pancreatic and β-cell nuclear transcription factor. reduced immunogenicity. In addition, the ability to maintain an undifferentiated status and normal karyo-SOX17 is expressed during human fetal pancreas development, when its transcription is significantly higher type during long-term in vitro culture is another critical advantage because expansion of the stem cell pool than in adult human islets (36) . The persistence of SOX17 mRNA expression thus may be explained by the before differentiation is required to eventually obtain a large number of transplantable surrogate β-cells. We arrest of a certain number of cells at DE/PF stages or may mirror its physiological postnatal expression. Nota-also found that cultured f-LSCs are able to form nonadherent spherical clusters, or limbospheres. The genera-bly, at stage 1 PDX1 staining was already detectable. PDX1 is a master regulator of pancreas development tion of spheres was first observed for progenitors/stem cells belonging to the central nervous system and neural and specification. During embryogenesis, PDX1 marks the prepancreatic endoderm before it has visibly thick-crest-derived tissue (30), and culture conditions developed for their formation are known to enrich stem-like ened (26) . Experiments of lineage tracing showed that at this stage PDX1 + cells represent progenitors of all the cells with self-renewal ability and differentiation potential. The self-renewal assays provided the proof of prin-mature pancreatic cell types, including duct, islet, and acinar cells (16) . PDX1 is subsequently silenced to even-ciple of the stem properties of f-LSCs.
Differentiation of f-LSCs into a surrogate β-cell type tually appear in the mature β-cell as a regulator of insulin gene transcription. The expression of PDX1 mRNA was achieved using factors and supplements, which have been described to direct and/or sustain differentiation of we observed during differentiation seems to mirror this biphasic pattern. other stem cells towards the pancreatic phenotype (6, 7, 20, 21, 24, 34) . Different concentrations, times of adminis-At stage 2, we further induced transition towards posterior foregut and pancreatic endoderm. A considerable tration, and lengths of application were tested in order to find the optimal conditions to induce β-cell differentiation upregulation of PDX1 at both mRNA and protein levels was observed, therefore confirming that the majority of through progressive stages of commitment that mimics normal pancreatic development. The expression of spe-f-LSCs (both in the monolayer and in the forming clusters) differentiated into pancreatic precursors. In particu-cific endodermal, pancreatic, islet, and β-cell markers, as well as functional properties of f-LSC-derived insulin-lar, many PDX1 + cells also coexpressed NKX6.1, which suggests transition towards the pancreatic epithelium. producing cells, were assessed during differentiation.
With our four-step approach, we first focused on Simultaneously, NGN3 became also detectable, indicating initial commitment to the endocrine lineage. NGN3 obtaining DE and PF (stages 1-2). The serum-free conditions, combined with the addition of activin A and its is transiently expressed during endocrine specification and is responsible of the induction of a battery of tran-subsequent removal, were critical in blocking f-LSC self-renewal and in inducing mesendoderm differentia-scription factors that constitute a "core program" of endocrine development (15) . They include ISL1, tion (5-7). Remarkably, cells started gathering in islet-like clusters, which progressively increased in size during NEUROD1, NKX6.1, and PAX4 genes, which are also known to act relatively late in β-cell specification (26) . a more mature phenotype. Indeed, the efficient conversion of proinsulin to insulin requires cleavages at both These factors were indeed detected already at the end of stage 2.
junctions of the connecting segment linking the B and A chains to release insulin and C-peptide. These products At the end of stage 2, we also observed upregulation of GLUT2 and GCK, two genes that play a crucial role normally are stored within the mature secretory granules. As the C-PEP/PROINS antibody used reacts spe-in maintaining blood glucose homeostasis, forming the so-called "β-cell glucose sensor" (19) . The early upregu-cifically with C-peptide and does not cross-react with insulin or other peptide hormones, the double staining lation of GLUT2, in absence of insulin detection, recalls the embryonic development phases when GLUT2 is for both C-peptide and insulin demonstrates that the hormone was efficiently processed. In addition, sustained expressed temporarily in pancreatic non-β-cells, likely acting as a signal for further development (18) . The protein synthesis was suggested by the observation that the hormone extensively filled and delineated the cyto-same finding has been described in GCG + cells during attempt of regeneration in STZ-diabetic nonhuman pri-plasm. At this stage the islet-like clusters increased consistently in number and size. Notably, in bigger islet-like mates (3).
During stage 3, maturation of pancreatic progenitors clusters C-PEP/PROINS was more marked in the cells of the inner core, while INS and GLUT2 staining was into hormone-producing cells and in particular β-cells, was allowed. Consistent with this observation, we stronger in outer cells. By contrast, smaller islet-like clusters showed a homogeneous insulin distribution. We observed remarkable upregulation of MAFA. This finding is extremely indicative, as no other characterized thus believe that the increased size of the aggregates may hinder or impair uniform exposure of inner cells to islet-enriched transcriptional factor is expressed exclusively in β-cells, where it functions as a potent activator medium and factors, leading to accumulation of proinsulin due to decreased cleavage of the prohormone. The of insulin gene transcription together with PDX1 and NEUROD1 (25, 42) . NGN3 mRNA and protein were granulated pattern observed by confocal microscopy suggested granules were docked in the cytoplasm of hor-undetectable in stage 3, suggesting that its expression is extinguished before the final differentiation of the hor-mone-producing cells. In addition, INS/SYP co-staining suggested the hormone was incorporated, at least tran-mone-producing cells. At this early stage of hormone maturation, however, C-peptide did not fill the cyto-siently, in secretory granules. This was also confirmed by electron microscopy, which revealed granules in the plasm, being stored in the apical pole of the cells.
Differentiation into fully competent hormone-produc-cytoplasm and next to the cell membrane. Co-staining of C-PEP with INS, MAFA, PDX1, and GLUT2 at day ing cells was completed by the end of stage 4, when the GLP-1 analog exendin-4 was added. Exendin-4 has been 15 confirmed maturation of cells. Assessment by flow cytometry at the end of differen-shown to increase β-cell replication, neogenesis, and expansion of the β-cell mass both in vitro and in vivo tiation showed that ϳ70% of the cells (and as many as 77%) eventually differentiated into cells expressing (37-39, 43) . At this stage C-PEP/PROINS and INS colocalized in immunofluorescence, indicating acquisition of insulin (assessed as C-peptide). These differentiation rates are about 10-fold higher than earlier in vitro studies cell pool before differentiation is required to eventually obtain a large number of transplantable surrogate β-(7,21). However, insulin gene transcription was about 20-fold lower compared to isolated human islets, sug-cells. Future studies are needed to refine the pancreatic differentiation protocols in order to improve the amount gesting that hormone production per cell is lower than in adult human β-cells. This observation is further sup-of functional mature surrogate β-cells. In addition, it should be determined whether potentiation of insulin ported by the finding that insulin content/µg total protein was about 160-fold lower than what observed in adult secretory function is induced in vivo, and ultimately assess the therapeutic potential of f-LSC-derived β-cells islets. Interestingly, differentiated cells processed ϳ98% of their proinsulin content, which is comparable to what after transplantation for the reversal of diabetes. is observed in mature β-cells. In addition, analysis of ACKNOWLEDGMENTS: We thank Sandra Pasqua Sisto the secretory function in response to glucose, tolbuta- stage of early fetal development (27, 41) . Thus, hormone
